| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |